EGFR mutation prediction using F18-FDG PET-CT based radiomics features in non-small cell lung cancer

Abstract

Lung cancer is the leading cause of cancer death in the world. Accurate determination of the EGFR (epidermal growth factor receptor) mutation status is highly relevant for the proper treatment of this patients. Purpose: The aim of this study was to predict the mutational status of the EGFR in non-small cell lung cancer patients using radiomics features extracted from PET-CT images. Methods: Retrospective study that involve 34 patients with lung cancer confirmed by histology and EGFR status mutation assessment. A total of 2.205 radiomics features were extracted from manual segmentation of the PET-CT images using pyradiomics library. Both computed tomography and positron emission tomography images were used. All images were acquired with intravenous iodinated contrast and F18-FDG. Preprocessing includes resampling, normalization, and discretization of the pixel intensity. Three methods were used for the feature selection process: backward selection (set 1), forward selection (set 2), and feature importance analysis of random forest model (set 3). Nine machine learning methods were used for radiomics model building. Results: 35.2% of patients had EGFR mutation, without significant differences in age, gender, tumor size and SUVmax. After the feature selection process 6, 7 and 17 radiomics features were selected, respectively in each group. The best performances were obtained by Ridge Regression in set 1: AUC of 0.826 (95% CI, 0.811 - 0.839), Random Forest in set 2: AUC of 0.823 (95% CI, 0.808 - 0.838) and Neural Network in set 3: AUC of 0.821 (95% CI, 0.808 - 0.835). Conclusion: The radiomics features analysis has the potential of predicting clinically relevant mutations in lung cancer patients through a non-invasive methodology.